Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study

BACKGROUND: This study compared the efficacy and safety of lixisenatide with placebo as add‐on therapy to basal insulin (BI) in adults aged ≥70 years with type 2 diabetes (T2D), with or without moderate renal insufficiency. METHODS: This post hoc analysis evaluated data from non‐frail patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Dailey, George E., Dex, Terry A., Roberts, Michelle, Liu, Minzhi, Meneilly, Graydon S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899823/
https://www.ncbi.nlm.nih.gov/pubmed/31094074
http://dx.doi.org/10.1111/1753-0407.12952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899823/
https://www.ncbi.nlm.nih.gov/pubmed/31094074
http://dx.doi.org/10.1111/1753-0407.12952

Ejemplares similares